{
    "title": "Merck's antiviral Covid pill 'molnupiravir' shows effectiveness against the Omicron variant in six lab studies",
    "url": "https://www.dailymail.co.uk/health/article-10452109/Mercks-COVID-19-pill-active-against-Omicron-lab-studies.html",
    "date": "2022-01-28",
    "keywords": [
        "molnupiravir",
        "drug",
        "omicron",
        "virus",
        "strain",
        "merck",
        "activity",
        "covid",
        "fda",
        "variant",
        "treatment",
        "pill",
        "ridgeback",
        "company",
        "concern",
        "effectiveness",
        "way",
        "fight",
        "share",
        "world",
        "data",
        "food",
        "administration",
        "role",
        "pandemic",
        "authorization",
        "antibody",
        "lab",
        "study",
        "confidence",
        "potential",
        "option",
        "mild",
        "risk",
        "disease",
        "li",
        "president",
        "research",
        "statementmolnupiravir",
        "light",
        "use",
        "viruspaxlovid",
        "pfizer",
        "blood",
        "article",
        "hospitalization",
        "death",
        "resource",
        "lot",
        "labor",
        "order",
        "pair",
        "home",
        "patient",
        "schedule",
        "person",
        "hospital",
        "bed",
        "monitoring",
        "health",
        "care",
        "workerwhile",
        "paxlovid",
        "standard",
        "competitor",
        "approval",
        "partnership",
        "pool",
        "success",
        "futureproof",
        "mechanism",
        "action",
        "tool",
        "covid19",
        "ceo",
        "holman",
        "saidomicron",
        "ability",
        "vaccinesbecause",
        "replicate",
        "code",
        "chance",
        "traitssome",
        "development",
        "problem",
        "humanity"
    ],
    "category": [
        "health"
    ]
}